Alaskas Oil Revival Drives Renewed Arctic Investment and Exploration SpaceX and OpenAI MegaIPOs Spark Market Top Debate Among Analysts Ebola Outbreak in DR Congo Red Cross Casualties Raise Regional Health and Economic Risks Piper Sandler Highlights Potential Pressure on Tractor Supply Amid Weak Pet Spending Trends Grain Bulls Attempt to Stabilize Corn Soybean and Wheat Markets Americans Feel Inflation Squeeze Ahead of Memorial Day Weekend Travel Food Costs Surge LYB Q1 2026 Earnings EPS Surges 140 Above Estimates Amid Improved Operations Team Inc TISI Q1 2026 Earnings Loss Per Share of 276 Reported Stock Edges Higher RXO Q1 2026 Earnings Narrowing Loss Beats Expectations Stock Edges Higher WaFd Inc WAFD Q1 2026 Earnings Strong EPS Beat Drives Confidence Amid Steady Performance STEX Q1 2026 Earnings Significant EPS Miss as Streamex Corp Reports WiderThanExpected Loss STX Q1 2026 Earnings Strong EPS Beat Amidst Data Center Demand Westamerica Bancorporation WABC Posts Modest Decline Holds Above Key Support Distribution Solutions Group DSGR Shows Modest Uptick Amid Consolidation Royalty Pharma RPRX Edges Higher Testing Resistance Near 57 Amid Steady Gains Silver Pegasus Acquisition Corp Rights SPEGR Holds Steady at 026 as Rights Approach Expiration Health Catalyst HCAT Surges 77 Testing Key Resistance Amid Renewed Buyer Interest White House and China Highlight Different Outcomes from TrumpXi Summit Soybean and Rare Earths Deals Tariff Cut Signals BSY Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Minerals Technologies MTX Holds Above Support as Consolidation Persists Europe Risks Dependency Trap in AI Trade with US and Asia Report Warns Retail Hiring Jumps Nearly 22000 in April as Consumer Warning Signs Emerge Barclays Reports 18 Profit Increase Lifts FullYear Income Guidance Prediction Market Suggests IonQ Micron and Anduril as Potential Next US Government Stake Targets Space Stocks Climb as SpaceX Prospectus Fuels Investor Optimism Despite Starship Setback LG Energy Solution Shares Surge 16 on Major US Battery Storage Deal Eli Lilly Commits 4 Billion to Vaccine Development in Trio of Deals